DEF: Myomo Inc. Schedules 2026 Annual Meeting, Proposes Share Increase

Myomo, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 25, 2026, to address key corporate governance and equity plan matters, including a significant increase in authorized common stock.

Summary

• Myomo, Inc. is holding its 2026 Annual Meeting of Stockholders virtually on June 25, 2026.
• Key proposals include the election of two Class III directors, an advisory vote on executive compensation, ratification of the independent auditor, and approval of amendments to the 2018 Stock Option and Incentive Plan and the company's certificate of incorporation.
• The proposed amendment to the certificate of incorporation seeks to increase the authorized shares of common stock from 65,000,000 to 100,000,000.
• An amendment to the 2018 Stock Option and Incentive Plan aims to increase the number of available shares by 1,833,000.
• A stockholder proposal regarding the declassification of the board of directors will be presented for an advisory vote, with the board making no recommendation.
• The record date for stockholders entitled to vote is April 29, 2026.
• Proxy materials are being made available online starting May 14, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, as it outlines standard corporate governance procedures and proposals aimed at future flexibility and growth, while also acknowledging past financial challenges and increased cash burn.

Positives

• The company is seeking to increase authorized shares, providing flexibility for future capital raises, strategic partnerships, acquisitions, and equity compensation.
• The proposed amendment to the stock option plan aims to enhance the company's ability to attract, retain, and motivate talent through competitive equity incentives.
• The virtual meeting format offers convenience and accessibility for all stockholders.
• The company is leveraging internet availability of proxy materials to reduce environmental impact and costs.

Negatives

• The company has generated net losses since inception, with a net loss increasing in 2025.
• Compensation actually paid in 2025 reflects lower stock price, slower revenue growth, higher cash burn, and a net loss, turning negative for the PEO and average non-PEO named executive officers.
• The company experienced lead generation challenges in 2025 due to changes in social media data usage, leading to fewer quality leads and higher cost per pipeline add, resulting in slower revenue growth and increased cash burn.
• One late Form 4 filing was reported for Thomas Crowley, Jr. in connection with share acquisition.

Risks

• The company faces risks related to its financial condition, development and commercialization activities, operations, strategic direction, and intellectual property, as detailed in its Form 10-K.
• The proposed increase in authorized shares could potentially lead to future dilution if not managed effectively.
• The company's stock price fell in 2025 due to lead generation challenges, impacting revenue growth and increasing cash burn.
• The company has generated net losses since inception, and the net loss increased in 2025.

Future Outlook

The company is seeking to increase its authorized shares and expand its equity incentive plan to provide flexibility for future capital needs, strategic initiatives, and employee retention, indicating a focus on future growth and operational flexibility.

Management Comments

• "Your vote is very important. Whether or not you plan to attend the virtual meeting, please carefully review the proxy materials and then cast your vote, regardless of the number of shares you hold."
• "We believe that we must continue to offer a competitive equity compensation program in order to attract, retain and motivate the talented and qualified employees necessary for our continued growth and success."
• "The board of directors unanimously recommends that you vote FOR the election of the director nominees, FOR the compensation of our named executive officers, FOR the ratification of the appointment of CBIZ, FOR the adoption of Amendment No. 3 to the 2018 Stock Option and Incentive Plan, and FOR the amendment to our certificate of incorporation to increase the number of authorized shares of common stock."
• "The board of directors is not making a recommendation on the advisory (non-binding) stockholder proposal regarding the classification of directors."

Industry Context

StockSavvy.ai notes that Myomo's proposals to increase authorized shares and amend its stock option plan are common strategies for growth-stage medical device companies seeking to fund operations, pursue strategic opportunities, and incentivize key personnel. The company's focus on equity compensation aligns with industry practices for attracting and retaining talent in a competitive market.

Comparison to Industry Standards

• The proposed increase in shares under the Amended 2018 Plan approximates 1,833,000 shares, based on a three-year average value-adjusted burn rate of 3.47%, which is below the ISS burn rate for non-Russell 3000 health care equipment companies of 8.23%.
• The company's three-year average value adjusted burn rate (2023-2025) of 3.47% is below the ISS industry category burn rate threshold of 8.23% for non-Russell 3000 health care equipment companies.
• The majority of U.S. public companies have phased out classified boards, with leading institutional investors and proxy advisory firms like ISS and Glass Lewis recommending for proposals to declassify boards due to governance benefits and director accountability.

Corporate Governance

Related Party Transactions

• AIGH Capital Management, a former 5% holder and associated with former director Yitzchak Jacobovitz, participated in the December 2024 Registered Public Offering ($1,000,000) and the January 2024 Registered Direct Offering ($1,499,952).
• Rosalind Master Fund L.P., a current 5% holder, participated in the December 2024 Registered Public Offering ($1,350,000) and the January 2024 Registered Direct Offering ($1,499,974).
• Triple Gate Partners LP, a former 5% holder, participated in the December 2024 Registered Public Offering ($1,350,000) and the January 2024 Registered Direct Offering ($599,640).

Stakeholder Impact

• Shareholders: Voting on director elections, executive compensation, equity plans, and share authorization directly impacts their ownership and potential future dilution. The advisory vote on board classification allows them to voice governance preferences.
• Employees: The proposed increase in the stock option plan aims to attract, retain, and motivate employees, potentially increasing their stake in the company's success.
• Management: Executive compensation is subject to advisory vote, and employment agreements outline severance packages.
• Creditors: Increased authorized shares could provide flexibility for future debt financing or equity-for-debt swaps, impacting the capital structure.

Next Steps

• Stockholders to vote on the proposals at the 2026 Annual Meeting of Stockholders on June 25, 2026.
• If approved, the amendment to the certificate of incorporation will be filed with the Secretary of State of the State of Delaware.
• If approved, Amendment No. 3 to the Myomo 2018 Stock Option and Incentive Plan will be adopted.
• Preliminary voting results will be announced at the Annual Meeting, with final results reported on Form 8-K within four business days.

Key Dates

Recommendation

The filing is a routine proxy statement for an annual meeting, outlining standard proposals. While it addresses future flexibility through share increases and equity plans, it also highlights recent financial challenges and increased cash burn. The company's stock price has been volatile, and the proposed actions, while strategic, do not immediately signal a significant improvement in financial performance. Therefore, a 'hold' recommendation is appropriate pending further operational and financial developments.

Keywords

Myomo Inc., Proxy Statement, Annual Meeting, Stockholders, Director Election, Executive Compensation, Independent Auditor, Stock Option Plan, Authorized Shares, Corporate Governance, DEF 14A